Nov 28, 2023 / 01:30PM GMT
Christopher Joseph Raymond - Piper Sandler & Co., Research Division - MD & Senior Research Analyst
Okay. I think we're going to go ahead and get started. Thanks, everybody, for being here. My name is Chris Raymond, I'm one of the biotech analysts here at Piper Sandler. Welcome the 35th Annual Piper Sandler Healthcare Conference. It's my pleasure to introduce our keynote company for today, Regeneron Pharmaceuticals.
Joining us, we have Regeneron's CFO, Bob Landry; along with Ryan Crowe, who heads up the Investor Relations effort at Regeneron. So just some logistical housekeeping issues maybe to cover first. I wanted to thank, however, Bob, for being here. I think this is likely your last investor conference before you formally work on your pickle ball game and golf game and anything else you want to do.
Well deserved and really (inaudible) working with you the last several years here. Maybe just to go over the format, we'll have a couple of minutes of introduction from Regeneron's forward-looking statements, et cetera, and then we'll go into this as informal as possible. So if you
Regeneron Pharmaceuticals Inc at Piper Sandler Healthcare Conference Transcript
Nov 28, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers